Table 2 Patient characteristics and surgical outcomes of bipolar transurethral electro vaporization of the prostate (B-TUVP) and holmium laser enucleation of the prostate (HoLEP) in patients with prostate volume > 80 ml
B-TUVP | HoLEP | P value * | ||
|---|---|---|---|---|
All patients | N=82 | N=115 | ||
Age(years-old) | 74.4 ± 7.5 | 73.0 ± 6.6 | 0.1 | |
Prostate volume (ml) | 119.4 ± 44.9 | 111.2 ± 29.8 | 0.1 | |
Operative time (mins) | 120.28 ± 31.0 | 164.6 ± 43.0 | <0.001 | |
Duration of post-operative catheterisation (days) | 3.0 ± 1.4 | 2.5 ± 1.2 | 0.009 | |
Hospital stay period after operation (days) | 6.8 ± 2.7 | 7.0 ± 2.8 | 0.2 | |
Hemoglobin (g/dl) | Change (%) | 96.0 ± 6.5 | 84 ± 10.6 | <0.001 |
Necessity of 2nd procedure | 8 (9.8%) | 3 (2.6%) | 0.03 | |
Uncatheterised patients | N = 48 | N = 76 | ||
Total IPSS | Pre | 20.3 ± 8.6 | 22.3 ± 8.4 | 0.295 |
1POM | 13.8 ± 8.2 | 8.8 ± 6.2 | 0.001 | |
Change (%) at 1POM | 86.0 ± 63.9 | 50.4 ± 64.2 | < 0.001 | |
3POM | 10.6 ± 8.0 | 6.0 ± 5.0 | 0.002 | |
Change (%) at 3POM | 62.2 ± 42.0 | 27.0 ± 20.0 | < 0.001 | |
IPSS-QoL | Pre | 4.9 ± 1.1 | 4.7 ± 1.3 | 0.581 |
1POM | 3.7 ± 1.7 | 2.5 ± 1.8 | 0.005 | |
Change (%) at 1POM | 78.5 ± 33.0 | 58.5 ± 72.2 | 0.005 | |
3POM | 2.9 ± 1.8 | 1.7 ± 1.5 | 0.002 | |
Change (%) at 3POM | 63.3 ± 39.0 | 30.7 ± 30.8 | 0.001 | |
Catheterised patients | N = 34 | N = 39 | ||
Achieving catheter free status after surgery | 24 (71%) | 39 (100%) | <0.001 |